Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06679855 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial

Study acronym: MIDAS
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv8
  2. Site details revised at 14 of 19 sitesv7
  3. Start date changed from estimate of May 14, 2025 to Jun 13, 2025v6
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jun 30, 2025 to May 14, 2025
    • Site details revised at 19 of 19 sites
    v5
  5. Start date: May 31, 2025 to Jun 30, 2025
    • Study completion date: Aug 31, 2029 to Jun 30, 2029
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Jun 2027 to Jun 30, 2027
    • Study completion date: Aug 2029 to Aug 31, 2029
    • Start date: May 2025 to May 31, 2025
    v3
  2. Start date: Feb 1, 2025 to May 2025
    • Primary completion date: Mar 2028 to Jun 2027
    • Study completion date: Apr 2030 to Aug 2029
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this Phase 3, randomized, masked clinical trial is to is to find out whether milrinone, when given to infants after PDA closure, will help the heart work better by supplying oxygen to the lungs and tissues. The main questions it aims to answer are: 1. to determine if milrinone decreases the risk of death or PLCS within 7 days of the procedure, compared to standard treatment; and 2. to determine the effects of milrinone on two-year survival and neurodevelopmental outcome.
Trial Details
NCT Number NCT06679855
Lead Sponsor NICHD Neonatal Research Network
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)		 Post-ligation Cardiac Syndrome
Enrollment 316 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov